A narrative literature review on traditional medicine options for treatment of corona virus disease 2019 (COVID-19).
TLDR
This review focuses on traditional medicine such as medicinal plant extracts as promising approaches against COVID-19, a life-threatening disease caused by severe acute respiratory syndrome coronavirus 2 that is accounted as global public health concern.About:
This article is published in Complementary Therapies in Clinical Practice.The article was published on 2020-06-17 and is currently open access. It has received 99 citations till now. The article focuses on the topics: Iranian traditional medicine.read more
Citations
More filters
Journal ArticleDOI
Corona Viruses: A Review on SARS, MERS and COVID-19
TL;DR: The case of COVID-19 was reported in the Hubei province of Wuhan city in Central China at the end of December 2019 and it is suspected that the sea food market played a role in this outbreak which was closed abruptly.
Journal ArticleDOI
Natural products can be used in therapeutic management of COVID-19: Probable mechanistic insights
TL;DR: In this article , the anti-viral potential of selected promising natural products was investigated in the context of therapeutic uses of phytoconstituents and their mechanism of action published in various reputed peer-reviewed journals.
Journal ArticleDOI
The Relevance of Complementary and Integrative Medicine in the COVID-19 Pandemic: A Qualitative Review of the Literature
Georg Seifert,Georg Seifert,Michael Jeitler,Rainer Stange,Andreas Michalsen,Holger Cramer,Holger Cramer,Benno Brinkhaus,Tobias Esch,Annette Kerckhoff,Anna Paul,Michael Teut,Pirus Ghadjar,Jost Langhorst,Thomas Häupl,Vijay Murthy,Christian S. Kessler +16 more
TL;DR: CIM offers a variety of preventive and therapeutic options for strengthening physical and mental resilience, which could also be useful in the current COVID-19 pandemic.
Journal ArticleDOI
Repurposing of Some Natural Product Isolates as SARS-COV-2 Main Protease Inhibitors via In Vitro Cell Free and Cell-Based Antiviral Assessments and Molecular Modeling Approaches.
Hossam M. Abdallah,Hossam M. Abdallah,Ali M. El-Halawany,Alaa Sirwi,Amr M. El-Araby,Gamal A. Mohamed,Gamal A. Mohamed,Sabrin R.M. Ibrahim,Abdulrahman E. Koshak,Hani Z. Asfour,Zuhier Awan,Mahmoud A. Elfaky +11 more
TL;DR: In this paper, a systematic computer-aided virtual screening approach was carried out using commercially available natural products found on the Zinc Database in addition to an in-house compound library to identify potential natural product inhibitors of SARS-CoV-2 main protease (MPRO).
Journal ArticleDOI
Facile Development of Graphene-Based Air Filters Mounted on 3D Printed Mask for COVID-19
Manoj Goswami,Manoj Goswami,Ashvini Kumar Yadav,Viplov Chauhan,Netrapal Singh,Netrapal Singh,Satendra Kumar,Satendra Kumar,Abhradeep Das,Abhradeep Das,Vishal Yadav,Vishal Yadav,Ajay Mandal,Ajay Mandal,Jitendar Kumar Tiwari,Jitendar Kumar Tiwari,Hafsa Siddiqui,Mohammad Ashiq,Mohammad Ashiq,N. Sathish,N. Sathish,Surender Kumar,Surender Kumar,Debasis Biswas,Avanish Kumar Srivastava +24 more
TL;DR: In this paper, a 3D printed facial mask replica was used to demonstrate the effectiveness of functionalized graphene (fG)-coated MB filters against SARS-CoV-2 viral particles.
References
More filters
Journal ArticleDOI
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang,Yeming Wang,Xingwang Li,Lili Ren,Jianping Zhao,Yi Hu,Li Zhang,Guohui Fan,Jiuyang Xu,Xiaoying Gu,Zhenshun Cheng,Ting Yu,Jia'an Xia,Yuan Wei,Wenjuan Wu,Xuelei Xie,Wen Yin,Li Hui,Min Liu,Yan Xiao,Hong Gao,Li Guo,Jungang Xie,Guang-Fa Wang,Rongmeng Jiang,Zhancheng Gao,Qi Jin,Jianwei Wang,Bin Cao +28 more
TL;DR: The epidemiological, clinical, laboratory, and radiological characteristics and treatment and clinical outcomes of patients with laboratory-confirmed 2019-nCoV infection in Wuhan, China, were reported.
Journal ArticleDOI
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.
Jonathan A C Sterne,Miguel A. Hernán,Barnaby C Reeves,Jelena Savović,Jelena Savović,Nancy D. Berkman,Meera Viswanathan,David Henry,Douglas G. Altman,Mohammed T. Ansari,Isabelle Boutron,James R. Carpenter,An-Wen Chan,Rachel Churchill,Jonathan J Deeks,Asbjørn Hróbjartsson,Jamie J Kirkham,Peter Jüni,Yoon K. Loke,Theresa D Pigott,Craig R Ramsay,Deborah L. Regidor,Hannah R. Rothstein,Lakhbir Sandhu,Pasqualina Santaguida,Holger J. Schünemann,Beverly Shea,Ian Shrier,Peter Tugwell,Lucy Turner,Jeffrey C. Valentine,Hugh Waddington,Elizabeth Waters,George A. Wells,Penny Whiting,Julian P T Higgins +35 more
TL;DR: Risk of Bias In Non-randomised Studies - of Interventions is developed, a new tool for evaluating risk of bias in estimates of the comparative effectiveness of interventions from studies that did not use randomisation to allocate units or clusters of individuals to comparison groups.
Journal ArticleDOI
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.
Bin Cao,Yeming Wang,Danning Wen,Wen Liu,Jingli Wang,Guohui Fan,Lianguo Ruan,Bin Song,Yanping Cai,Ming Wei,Xingwang Li,Jia'an Xia,Nanshan Chen,Jie Xiang,Ting Yu,Tao Bai,Xuelei Xie,Li Zhang,Caihong Li,Ye Yuan,Hua Chen,Huadong Li,Hanping Huang,Shengjing Tu,Fengyun Gong,Ying Liu,Yuan Wei,Chongya Dong,Fei Zhou,Xiaoying Gu,Jiuyang Xu,Zhibo Liu,Yi Zhang,Li Hui,Lianhan Shang,Ke Wang,Kunxia Li,Xia Zhou,Xuan Dong,Zhaohui Qu,Sixia Lu,Xujuan Hu,Shunan Ruan,Shanshan Luo,Jing Wu,Lu Peng,Fang Cheng,Lihong Pan,Jun Zou,Chunmin Jia,Juan Wang,Xia Liu,Shuzhen Wang,Xudong Wu,Qin Ge,Jing He,Haiyan Zhan,Fang Qiu,Li Guo,Chaolin Huang,Thomas Jaki,Frederick G. Hayden,Peter Horby,Dingyu Zhang,Chen Wang +64 more
TL;DR: In hospitalized adult patients with severe Covid-19, no benefit was observed with lopinavir–ritonavir treatment beyond standard care, and future trials in patients withsevere illness may help to confirm or exclude the possibility of a treatment benefit.
Journal ArticleDOI
Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study.
TL;DR: It is inferred that epidemics are already growing exponentially in multiple major cities of China with a lag time behind the Wuhan outbreak of about 1–2 weeks, and that other major Chinese cities are probably sustaining localised outbreaks.
Related Papers (5)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang,Yeming Wang,Xingwang Li,Lili Ren,Jianping Zhao,Yi Hu,Li Zhang,Guohui Fan,Jiuyang Xu,Xiaoying Gu,Zhenshun Cheng,Ting Yu,Jia'an Xia,Yuan Wei,Wenjuan Wu,Xuelei Xie,Wen Yin,Li Hui,Min Liu,Yan Xiao,Hong Gao,Li Guo,Jungang Xie,Guang-Fa Wang,Rongmeng Jiang,Zhancheng Gao,Qi Jin,Jianwei Wang,Bin Cao +28 more
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou,Xing-Lou Yang,Xian Guang Wang,Ben Hu,Lei Zhang,Wei Zhang,Hao Rui Si,Yan Zhu,Bei Li,Chao Lin Huang,Hui-Dong Chen,Jing Chen,Yun Luo,Hua Guo,Ren Di Jiang,Meiqin Liu,Ying Chen,Xu Rui Shen,Xi Wang,Xiao Shuang Zheng,Kai Zhao,Quanjiao Chen,Fei Deng,Lin Lin Liu,Bing Yan,Fa Xian Zhan,Yan-Yi Wang,Gengfu Xiao,Zhengli Shi +28 more